PMS-METHOTREXATE INJECTION

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 0728b9f86c9f6795
Drug Approval Canada Name: PMS-METHOTREXATE INJECTION
Product Name: PMS-METHOTREXATE INJECTION
Status: Marketed
Status Date: 2024-03-14
Original Market Date: 2024-03-14
Din: 02539659
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L04AX03 METHOTREXATE
Atc Name: l 04 ax 03
Aig Number: 0107545005
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

METHOTREXATE (METHOTREXATE SODIUM)

22.5 MG / 0.45 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

0728b9f86c9f6795

Type

Standard